Understanding iDose® TR: A Breakthrough in Glaucoma Treatment thumbnail

Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

Published Dec 03, 24
1 min read


iDose® TR marks a significant breakthrough in the treatment of glaucoma, providing a consistent and reliable option for managing intraocular pressure (IOP). Differing from traditional eye drops that require daily administration, iDose® TR is a small, implantable device designed to deliver a controlled medication delivery directly into the eye over an extended period. This cutting-edge approach eliminates the need for frequent dosing, significantly improving patient adherence and overall treatment results.

At Eye Center South, we are proud to offer iDose® TR as part of our holistic glaucoma care. The device is implanted during a gentle procedure, focused on your comfort and ease. Once in place, it ensures a steady release of glaucoma medication, helping to maintain stable IOP levels and ensuring your visual health. Patients who have difficulty managing the demands of frequent eye drop use can benefit greatly from this cutting-edge treatment.



Visit for more info At Eye Center South